200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 35766-04-2
35766-04-2 | 1H,3H-Thiazolo[3,4-a]benzimidazole(9CI)
CAS No: 35766-04-2 Catalog No: AG00CX7I MDL No:
Product Description
Catalog Number:
AG00CX7I
Chemical Name:
1H,3H-Thiazolo[3,4-a]benzimidazole(9CI)
CAS Number:
35766-04-2
IUPAC Name:
1,3-dihydro-[1,3]thiazolo[3,4-a]benzimidazole
InChI:
InChI=1S/C9H8N2S/c1-2-4-8-7(3-1)10-9-5-12-6-11(8)9/h1-4H,5-6H2
InChI Key:
CEZGFQCGXLQKCP-UHFFFAOYSA-N
NSC Number:
624051
Properties
Complexity:
185
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
176.041g/mol
Formal Charge:
0
Heavy Atom Count:
12
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
176.237g/mol
Monoisotopic Mass:
176.041g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
43.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.7
Literature
| Title | Journal |
|---|---|
| Yet another ten stories on antiviral drug discovery (part D): paradigms, paradoxes, and paraductions. | Medicinal research reviews 20100701 |
| Anti-HIV agents: design and discovery of new potent RT inhibitors. | Farmaco (Societa chimica italiana : 1989) 20030301 |
| Synthesis and antitumour activity of 1H,3H-thiazolo[3,4-a]benzimidazole derivatives. | Archiv der Pharmazie 20010601 |
| Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitors. | Antiviral chemistry & chemotherapy 20010501 |
| Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. | Journal of virology 19930401 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.